Variant report
Variant | nsv522543 |
---|---|
Chromosome Location | chr8:85164821-85165783 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2130985 | chr8:85164821-85164822 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs193206530 | chr8:85164831-85164832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539084264 | chr8:85164842-85164843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549320603 | chr8:85164846-85164847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569874329 | chr8:85164850-85164851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185581269 | chr8:85164852-85164853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555282907 | chr8:85164854-85164855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs570922796 | chr8:85164865-85164866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376760906 | chr8:85164973-85164974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538028541 | chr8:85164998-85164999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116937050 | chr8:85165007-85165008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188610719 | chr8:85165011-85165012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556351308 | chr8:85165015-85165016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554346607 | chr8:85165021-85165022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577401269 | chr8:85165044-85165045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372405140 | chr8:85165151-85165152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16912615 | chr8:85165211-85165212 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs572186512 | chr8:85165236-85165237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562870465 | chr8:85165244-85165245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531924116 | chr8:85165247-85165248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7009763 | chr8:85165258-85165259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569683764 | chr8:85165285-85165286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369383598 | chr8:85165335-85165336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376448511 | chr8:85165338-85165339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143868328 | chr8:85165360-85165361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7009916 | chr8:85165365-85165366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150190341 | chr8:85165378-85165379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372124387 | chr8:85165386-85165387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574784652 | chr8:85165394-85165395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13263557 | chr8:85165407-85165408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13263566 | chr8:85165412-85165413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149378273 | chr8:85165506-85165507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369611237 | chr8:85165517-85165518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192992151 | chr8:85165533-85165534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535716220 | chr8:85165600-85165601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569594840 | chr8:85165699-85165700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535390269 | chr8:85165714-85165715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549305030 | chr8:85165754-85165755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10094547 | chr8:85165783-85165784 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:85156200-85166000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr8:85156200-85169400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr8:85161000-85165000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr8:85161000-85165800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr8:85161200-85165800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:85164600-85166400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr8:85164800-85165400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr8:85165000-85166200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr8:85165000-85167400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr8:85165400-85178000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr8:85165600-85166400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |